Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
35.02
+0.25 (0.72%)
Oct 29, 2025, 11:37 AM EDT - Market open
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $3.37 billion as of October 29, 2025. Its market cap has decreased by -32.15% in one year.
Market Cap
3.37B
Enterprise Value
3.69B
1-Year Change
-32.15%
Ranking
Category
Stock Price
$35.02
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $3.37B, an increase of 183.36%. That is a compound annual growth rate of 9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 3.40B | -12.41% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 250.89B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |